| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $448.1M | $493.7M | $521.3M |
| YoY Revenue Growth % | -9.2% | -5.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$43.7M | -$87.1M | -$129.6M |
| Operating Margin % | -9.8% | -17.6% | -24.9% |
| Net Income (GAAP) | -$56.3M | -$14.0M | -$136.6M |
| EBITDA (Normalized) | -$39.4M | -$83.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$515.0K | -$55.3M | $62.0K |
| Capital Expenditures (CapEx) | $5.4M | $5.0M | — |
| Free Cash Flow (FCF) | -$5.9M | -$60.4M | $62.0K |
| FCF Margin % | -1.3% | -12.2% | 0.0% |
| Return on Invested Capital (ROIC %) | -9.7% | -23.0% | — |
| Cash & Short-Term Equivalents | $96.8M | $130.6M | — |
| Total Debt (Short + Long Term) | $40.0M | $0 | — |
| Total Stockholders' Equity | $414.1M | $429.1M | — |